Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with all data for entry = 6137
TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111496BDBM111496(US8618286, 22)
Affinity DataIC50: 14nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111497BDBM111497(US8618286, 23)
Affinity DataIC50: 28nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111490BDBM111490(US8618286, 16)
Affinity DataIC50: 34nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111498BDBM111498(US8618286, 24)
Affinity DataIC50: 50nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111482BDBM111482(US8618286, 8)
Affinity DataIC50: 60nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111484BDBM111484(US8618286, 10)
Affinity DataIC50: 80nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111502BDBM111502(US8618286, 28)
Affinity DataIC50: 80nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111503BDBM111503(US8618286, 29)
Affinity DataIC50: 110nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111486BDBM111486(US8618286, 12)
Affinity DataIC50: 120nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111501BDBM111501(US8618286, 27)
Affinity DataIC50: 130nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111495BDBM111495(US8618286, 21)
Affinity DataIC50: 140nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111493BDBM111493(US8618286, 19)
Affinity DataIC50: 140nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111488BDBM111488(US8618286, 14)
Affinity DataIC50: 140nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111489BDBM111489(US8618286, 15)
Affinity DataIC50: 150nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111500BDBM111500(US8618286, 26)
Affinity DataIC50: 150nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111494BDBM111494(US8618286, 20)
Affinity DataIC50: 160nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111487BDBM111487(US8618286, 13)
Affinity DataIC50: 190nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111480BDBM111480(US8618286, 6)
Affinity DataIC50: 200nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111483BDBM111483(US8618286, 9)
Affinity DataIC50: 200nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111499BDBM111499(US8618286, 25)
Affinity DataIC50: 200nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111485BDBM111485(US8618286, 11)
Affinity DataIC50: 240nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111478BDBM111478(US8618286, 4)
Affinity DataIC50: 410nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111476BDBM111476(US8618286, 2)
Affinity DataIC50: 430nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111492BDBM111492(US8618286, 18)
Affinity DataIC50: 660nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111477BDBM111477(US8618286, 3)
Affinity DataIC50: 850nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111481BDBM111481(US8618286, 7)
Affinity DataIC50: 1.06E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111491BDBM111491(US8618286, 17)
Affinity DataIC50: 1.16E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111477BDBM111477(US8618286, 3)
Affinity DataIC50: 1.50E+3nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111479BDBM111479(US8618286, 5)
Affinity DataIC50: 1.84E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, brain(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111475BDBM111475(US8618286, 1)
Affinity DataIC50: 2.08E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111478BDBM111478(US8618286, 4)
Affinity DataIC50: 2.70E+3nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111484BDBM111484(US8618286, 10)
Affinity DataIC50: 3.74E+3nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111484BDBM111484(US8618286, 10)
Affinity DataIC50: 3.82E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111498BDBM111498(US8618286, 24)
Affinity DataIC50: 4.45E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111490BDBM111490(US8618286, 16)
Affinity DataIC50: 7.00E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111483BDBM111483(US8618286, 9)
Affinity DataIC50: 7.25E+3nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111500BDBM111500(US8618286, 26)
Affinity DataIC50: 8.48E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111502BDBM111502(US8618286, 28)
Affinity DataIC50: 8.58E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111487BDBM111487(US8618286, 13)
Affinity DataIC50: 9.92E+3nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111495BDBM111495(US8618286, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111481BDBM111481(US8618286, 7)
Affinity DataIC50: 1.04E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111476BDBM111476(US8618286, 2)
Affinity DataIC50: 1.06E+4nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, inducible(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111480BDBM111480(US8618286, 6)
Affinity DataIC50: 1.09E+4nMAssay Description:Recombinant human inducible NOS (iNOS) was produced in Baculovirus-infected Sf9 cells (ALEXIS). In a radiometric method, NO synthase activity was det...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111476BDBM111476(US8618286, 2)
Affinity DataIC50: 1.09E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111491BDBM111491(US8618286, 17)
Affinity DataIC50: 1.09E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111488BDBM111488(US8618286, 14)
Affinity DataIC50: 1.15E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111496BDBM111496(US8618286, 22)
Affinity DataIC50: 1.21E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111492BDBM111492(US8618286, 18)
Affinity DataIC50: 1.26E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111477BDBM111477(US8618286, 3)
Affinity DataIC50: 1.38E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

TargetNitric oxide synthase, endothelial(Human)
Neuraxon

US Patent
LigandChemical structure of BindingDB Monomer ID 111499BDBM111499(US8618286, 25)
Affinity DataIC50: 1.81E+4nMAssay Description:Primary stock solutions of test compounds at a concentration of 6 mM were prepared from the 2 to 5 mg powder. The primary stock solutions of each tes...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/8/2014
Entry Details
US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: